# MetaCenTherapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/metacentherapeutics

- Industry: Biotechnology
- Headquarters: Gyeonggi-do, South Korea
- Website: www.metacen.com
- Total disclosed funding: $9.3M
- Latest round: Series B (Apr 15, 2021)
- Investors on record: 6

## About

Based in Suwon, South Korea, and founded in 2015, K-Medicoop Co., Ltd, doing business as MetaCenTherapeutics, operates as a biotechnology firm that develops drugs used to treat metabolic diseases, as well as a manufacturer of medical food. In April 2021, MetaCenTherapeutics raised KRW 6.2 billion in series B funding led by DA Value Investment, with the participation of Vision Creator.

MetaCenTherapeutics is a developer of a business collaboration system aimed at delivering safe therapeutic products with precise instructions. Furthermore, the company provides medical food, skincare, and drug solutions in disease areas where there are significant unmet needs, allowing clients to achieve professional products that lead the innovative market. The company's pharmaceutical products decompose and discharge sugar toxins that are produced in or introduced into the body.

The company plans to use the April 2021 funding to develop medical food and new drugs capable of decomposing and releasing mycotoxins.

## Funding rounds

- Series B, Apr 15, 2021, $5.6M — DA Value Investment
- Series A, Feb 28, 2017, $2.8M — L&S Venture Capital, SJ Investment Partners, Midas Donga Investment, K-Run Ventures, J-one Capital Invest
- Seed, Aug 20, 2016, $0.9M — L&S Venture Capital, K-Run Ventures

## Investors

- L&S Venture Capital (https://capitalatlas.ai/funds/l-s-venture-capital) — Seed, Series A
- K-Run Ventures (https://capitalatlas.ai/funds/k-run-ventures) — Seed, Series A
- SJ Investment Partners (https://capitalatlas.ai/funds/sj-investment-partners) — Series A
- Midas Donga Investment (https://capitalatlas.ai/funds/midas-donga-investment) — Series A
- J-one Capital Invest (https://capitalatlas.ai/funds/j-one-capital-invest) — Series A
- DA Value Investment (https://capitalatlas.ai/funds/da-value-investment) — Series B